NasdaqGS - Nasdaq Real Time Price USD

Azenta, Inc. (AZTA)

Compare

51.44

-0.83

(-1.59%)

At close: 4:00:02 PM EST

51.62

+0.18

+(0.35%)

After hours: 5:36:39 PM EST

Azenta (NASDAQ:AZTA) shareholders have endured a 51% loss from investing in the stock three years ago

Azenta, Inc. ( NASDAQ:AZTA ) shareholders should be happy to see the share price up 11% in the last month. But that is...

Simply Wall St. 15 days ago

AZTA
-1.59%
Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?

While Azenta, Inc. ( NASDAQ:AZTA ) might not have the largest market cap around , it saw a double-digit share price...

Simply Wall St. last month

AZTA
-1.59%
Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks

Azenta, Inc. (AZTA) has disclosed a new risk, in the Environmental / Social category. Azenta, Inc. faces significant business risks due to its need to comply with a complex and evolving landscape of data protection laws and regulations across the globe. The company is subject to U.S. federal and state laws, including the California Consumer Privacy Act and the California Privacy Rights Act, as well as international regulations like the EU GDPR and UK GDPR, all of which impose stringent requireme

TipRanks last month

AZTA
-1.59%
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:

PR Newswire last month

FLEX

SPGI

ENV
Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14%

The analysts covering Azenta, Inc. ( NASDAQ:AZTA ) delivered a dose of negativity to shareholders today, by making a...

Simply Wall St. last month

AZTA
-1.59%
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholders might have noticed that Azenta, Inc. ( NASDAQ:AZTA ) filed its full-year result this time last week. The...

Simply Wall St. last month

AZTA
-1.59%
Azenta to Participate in Stephens Annual Investment Conference

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024, which includes a presentation beginning at 1:00 pm CT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

PR Newswire last month

AZTA
-1.59%
Calculating The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Key Insights Azenta's estimated fair value is US$44.89 based on 2 Stage Free Cash Flow to Equity Current share price of...

Simply Wall St. last month

AZTA
-1.59%
Azenta Full Year 2024 Earnings: EPS Misses Expectations

Azenta ( NASDAQ:AZTA ) Full Year 2024 Results Key Financial Results Revenue: US$656.3m (down 1.3% from FY 2023). Net...

Simply Wall St. last month

AZTA
-1.59%
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...

Azenta Inc (AZTA) reports steady revenue and margin expansion while addressing market pressures and operational complexities.

GuruFocus.com 2 months ago

AZTA
-1.59%
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024.

PR Newswire 2 months ago

AZTA
-1.59%
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes.

PR Newswire 2 months ago

AZTA
-1.59%
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced the appointment of three new independent directors to its Board.

PR Newswire 2 months ago

AZTA
-1.59%
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States.

PR Newswire 2 months ago

AZTA
-1.59%
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.

PR Newswire 4 months ago

AZTA
-1.59%
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20. GENEWIZ Week will showcase our commitment to providing cutting-edge solutions to researchers worldwide through a series of workshops, an awards program, and engaging prizes and promotions.

PR Newswire 5 months ago

AZTA
-1.59%
Azenta Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Azenta ( NASDAQ:AZTA ) Third Quarter 2024 Results Key Financial Results Revenue: US$172.8m (up 4.1% from 3Q 2023). Net...

Simply Wall St. 5 months ago

AZTA
-1.59%
Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2024.

PR Newswire 5 months ago

AZTA
-1.59%
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes.

PR Newswire 5 months ago

AZTA
-1.59%
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants.

PR Newswire 5 months ago

AZTA
-1.59%

Performance Overview

Return	AZTA	S&P 500
YTD	+2.98%	-1.08%
1-Year	-21.03%	+22.14%
3-Year	-41.41%	+25.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Azenta, Inc. (AZTA)

Azenta (NASDAQ:AZTA) shareholders have endured a 51% loss from investing in the stock three years ago

Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?

Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14%

Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Azenta to Participate in Stephens Annual Investment Conference

Calculating The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Azenta Full Year 2024 Earnings: EPS Misses Expectations

Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

Azenta Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Performance Overview